Abstract
Background Chronic musculoskeletal pain is among the most significant burdens to society. Despite years of research on effective interventions for managing chronic musculoskeletal (MSK) pain, most interventions have not reached clinical practice, underlining the significant implementation gap. Hence, understanding existing barriers and facilitators for implementing interventions may add crucial insights to guide future implementation efforts. This study aimed to identify barriers and facilitators for implementing interventions for managing patients with chronic MSK pain across healthcare settings.
Methods We conducted a scoping review guided by the approach developed the Joanna Briggs Institute. The search was conducted in MEDLINE, EMBASE, CINAHL, PubMed, and PsycINFO from inception to December, 2023. We included peer-reviewed qualitative studies exploring perspectives of implementing interventions for patients living with chronic MSK pain (aged 18+ years) and healthcare professionals (HCPs) in any healthcare setting, published within the last 20 years. Quantitative studies and studies in languages other than English were excluded. Two authors independently selected the studies and extracted the data. We used General Inductive Approach to analyze the included studies. Secondly, we mapped the extracted data items to the Theoretical Domains Framework (TDF) to identify prevalent and salient barriers and challenges across the included studies.
Results From 18.220 records, we included 22 studies involving 307 HCPs and 76 patients. Studies from all healthcare sectors were represented. Six major themes and six sub-themes were identified. The major themes were: 1) Long way from usual care, 2) Trust and commitment, 3) Support, 4) Time and finance, 5). Knowledge and skills and 6) What patients want. Across both groups, the TDF domain ‘Environmental Context and Resources’ was the most frequently reported barrier and facilitator for implementing the intervention (Barriers: HCP n = 84, 23.5%; patient n = 15, 4.2%; Facilitators: HCP n = 44, 16.6%; patient n = 10, 3.8%).
Conclusion This scoping review identified barriers and facilitators to implementing interventions for the management of chronic musculoskeletal pan across individual, organizational, and political levels. Our analysis identified barriers including time constraints, low reimbursement rates, and insufficient support, while facilitators centered on leadership, communication, and social networks were identified. Targeted strategies addressing these barriers and facilitators are critical to enhancing sustainable and effective implementation in clinical practice in order to improve care of chronic musculoskeletal pain.
Trial registration Open Science Framework, DOI 10.17605/OSF.IO/VZP9W
Contributions to the literature
- The current study is the first qualitative scoping review of barriers and facilitators for implementing interventions for patients with chronic MSK pain across multiple healthcare settings.
- Across healthcare settings barriers and facilitators exist across several levels, and highlighted from the theoretical domains framework, the environment, context, and resources (ECR) are among the most prominent barriers and facilitators for both HCPs and patients.
- This review’s findings add to existing implementation science literature by highlighting potential underlying contextual factors influencing intervention acceptance, such as the experience of ‘long way from usual care’.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵x Shared first authorship.
No large language models have been used to write this manuscript.
mdk{at}fdaalborg.dk, lil{at}nfa.dk, skjohansen{at}dcm.aau.dk, misr{at}hst.aau.dk, klyng{at}dcm.aau.dk
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos